Page last updated: 2024-09-03

candoxatrilat and enalapril

candoxatrilat has been researched along with enalapril in 3 studies

Compound Research Comparison

Studies
(candoxatrilat)
Trials
(candoxatrilat)
Recent Studies (post-2010)
(candoxatrilat)
Studies
(enalapril)
Trials
(enalapril)
Recent Studies (post-2010) (enalapril)
461016,3111,924859

Protein Interaction Comparison

ProteinTaxonomycandoxatrilat (IC50)enalapril (IC50)
Angiotensin-converting enzyme Homo sapiens (human)0.3536
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)2.7083
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)1.2
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.14
Angiotensin-converting enzyme 2 Homo sapiens (human)0.14

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbenante, G; Fairlie, DP; Leung, D1
Cramb, G; Lang, CC; Motwani, JG; Struthers, AD1
Ferro, CJ; Haynes, WG; Spratt, JC; Webb, DJ1

Reviews

1 review(s) available for candoxatrilat and enalapril

ArticleYear
Protease inhibitors: current status and future prospects.
    Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3

    Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors

2000

Trials

2 trial(s) available for candoxatrilat and enalapril

ArticleYear
Natriuretic response to neutral endopeptidase inhibition is blunted by enalapril in healthy men.
    Hypertension (Dallas, Tex. : 1979), 1995, Volume: 25, Issue:4 Pt 1

    Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Cyclohexanecarboxylic Acids; Double-Blind Method; Drug Interactions; Enalapril; Glomerular Filtration Rate; Humans; Male; Natriuresis; Neprilysin; Renal Circulation; Single-Blind Method

1995
Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.
    Circulation, 1998, Jun-16, Volume: 97, Issue:23

    Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Coronary Vessels; Cross-Over Studies; Cyclohexanecarboxylic Acids; Enalapril; Endothelin-1; Humans; Hypertension; Injections, Intra-Arterial; Male; Middle Aged; Myocardium; Neprilysin; Peptides, Cyclic; Protease Inhibitors; Renin; Single-Blind Method; Thiorphan; Vasoconstriction

1998